156 results on '"Vance, M. L."'
Search Results
2. Diagnosis and treatment of acromegaly complications
3. Guidelines for Acromegaly Management: An Update
4. Treatment of Adrenocorticotropin-Dependent Cushingʼs Syndrome: A Consensus Statement
5. Trattamento a lungo termine dell’acromegalia mediante pegvisomant, un antagonista del recettore dell’ormone della crescita
6. Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
7. The Pharmacokinetic and Pharmacodynamic Characteristics of a Long-Acting Growth Hormone (GH) Preparation (Nutropin Depot) in GH-Deficient Adults
8. Guidelines for Acromegaly Management
9. Surgical Management of GH-Secreting Pituitary Adenomas: An Outcome Study Using Modern Remission Criteria
10. Estrogen Receptors in Prolactinomas: A Clinico-Pathological study
11. Clinical Aspects of Dopamine in the Regulation of Human Anterior Pituitary Function
12. Confronto tra chirurgia endoscopica e microchirurgia transsfenoidale per l’acromegalia: risultati in una serie parallela di pazienti usando i moderni criteri di remissione
13. La chirurgia endoscopica transfenoidale per l’acromegalia: remissione usando criteri moderni, complicanze e fattori predittivi dell’outcome
14. Therapeutic Effects of Growth Hormone Releasing Hormone
15. Hyperprolactinaemic infertility: some considerations on medical management
16. Clinical Aspects of Growth Hormone Hypersecretory States
17. X-linked acrogigantism: a new condition of growth hormone excess
18. Sandostatin®(SMS 201–995) in the Treatment of Acromegaly
19. Hyperprolactinaemic infertility: some considerations on medical management
20. The Role of Brain Dopamine
21. Growth-Hormone-Releasing Factor: Clinical Considerations
22. Consensus statement: medical management of acromegaly
23. PERIOPERATIVE ACTH CHANGES PREDICT OUTCOME DURING TRANSSPHENOIDAL MICROSURGERY FOR CUSHING??S DISEASE
24. Treatment of prolactin-secreting macroadenomas with the once-weekly dopamine agonist cabergoline.
25. Fasting as a metabolic stress paradigm selectively amplifies cortisol secretory burst mass and delays the time of maximal nyctohemeral cortisol concentrations in healthy men.
26. Circulating dihydroxyphenylglycol and norepinephrine concentrations during sympathetic nervous system activation in patients with pheochromocytoma.
27. Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release.
28. Growth and the Child with Diabetes Mellitus
29. Amplitude suppression of the pulsatile mode of immunoradiometric luteinizing hormone release in fasting-induced hypoandrogenemia in normal men.
30. Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide. Results of the International Multicenter Acromegaly Study Group
31. Temporal structure of in vivo growth hormone secretory events in humans
32. Growth-hormone-releasing hormone
33. Treatment of prolactin-secreting pituitary macroadenomas with the long-acting non-ergot dopamine agonist CV 205-502.
34. Drugs five years later. Bromocriptine.
35. Growth-hormone-releasing hormone: a clinical update.
36. Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuation.
37. Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Evidence for intermittent somatostatin secretion.
38. Metabolic clearance and plasma disappearance rates of human pancreatic tumor growth hormone releasing factor in man.
39. Growth hormone, 1988.
40. Effects of an Oral Ghrelin Mimetic on Body Composition and Clinical Outcomes in Healthy Older Adults.
41. Neuroendocrine regulation of growth hormone secretion
42. Multidisciplinary management of acromegaly: a consensus
43. Topology of Dopamine Receptors
44. The Role of Dopamine in the Control of Neurobiological Functions
45. Dopamine Receptors in the Central Nervous System
46. OUTCOMES AFTER REPEAT TRANSSPHENOIDAL SURGERY FOR RECURRENT CUSHING'S DISEASE
47. Diagnosis and treatment of acromegaly complications
48. Cushing's disease resulting from pituitary corticotrophic microadenoma. Treatment results from transsphenoidal microsurgery and gamma knife radiosurgery.
49. Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist.
50. Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.